

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to interleukin-15 (GO:0070672) | 4.20366013 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.15043840 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.15043840 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04251765 |
| 5 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.84519564 |
| 6 | cellular response to interleukin-15 (GO:0071350) | 3.77665861 |
| 7 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72755242 |
| 8 | tryptophan catabolic process (GO:0006569) | 3.69040910 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 3.69040910 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 3.69040910 |
| 11 | fucose catabolic process (GO:0019317) | 3.55814246 |
| 12 | L-fucose metabolic process (GO:0042354) | 3.55814246 |
| 13 | L-fucose catabolic process (GO:0042355) | 3.55814246 |
| 14 | negative thymic T cell selection (GO:0045060) | 3.54532872 |
| 15 | negative T cell selection (GO:0043383) | 3.53772540 |
| 16 | kynurenine metabolic process (GO:0070189) | 3.47895499 |
| 17 | regulation of regulatory T cell differentiation (GO:0045589) | 3.37230592 |
| 18 | behavioral response to nicotine (GO:0035095) | 3.33385233 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.30349351 |
| 20 | indolalkylamine metabolic process (GO:0006586) | 3.29189663 |
| 21 | COPI coating of Golgi vesicle (GO:0048205) | 3.25442945 |
| 22 | Golgi transport vesicle coating (GO:0048200) | 3.25442945 |
| 23 | interferon-gamma production (GO:0032609) | 3.22086454 |
| 24 | positive T cell selection (GO:0043368) | 3.15632956 |
| 25 | activated T cell proliferation (GO:0050798) | 3.12154578 |
| 26 | protein targeting to Golgi (GO:0000042) | 3.11777338 |
| 27 | thymic T cell selection (GO:0045061) | 3.07278828 |
| 28 | tryptophan metabolic process (GO:0006568) | 3.05688120 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 3.05227210 |
| 30 | positive thymic T cell selection (GO:0045059) | 3.04811494 |
| 31 | T cell selection (GO:0045058) | 3.02857633 |
| 32 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.01780556 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.95358325 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 2.91418752 |
| 35 | establishment of protein localization to Golgi (GO:0072600) | 2.90172004 |
| 36 | positive regulation of humoral immune response (GO:0002922) | 2.89716812 |
| 37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89301105 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89301105 |
| 39 | tolerance induction (GO:0002507) | 2.88600446 |
| 40 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.84816608 |
| 41 | detection of light stimulus involved in visual perception (GO:0050908) | 2.84816608 |
| 42 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.84179992 |
| 43 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.82615914 |
| 44 | protein K11-linked deubiquitination (GO:0035871) | 2.81268987 |
| 45 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.80601133 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77396545 |
| 47 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.77253449 |
| 48 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.73263956 |
| 49 | T-helper cell differentiation (GO:0042093) | 2.71528695 |
| 50 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.71528695 |
| 51 | regulation of memory T cell differentiation (GO:0043380) | 2.68564211 |
| 52 | cellular response to ethanol (GO:0071361) | 2.68200769 |
| 53 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.67502798 |
| 54 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.67502798 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 2.67446340 |
| 56 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.67402299 |
| 57 | growth hormone receptor signaling pathway (GO:0060396) | 2.65783309 |
| 58 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.65502987 |
| 59 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.64875750 |
| 60 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.63568012 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.63568012 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63459016 |
| 63 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.61149596 |
| 64 | positive regulation of B cell mediated immunity (GO:0002714) | 2.61149596 |
| 65 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.60403963 |
| 66 | amine catabolic process (GO:0009310) | 2.60308326 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 2.60308326 |
| 68 | positive regulation of isotype switching (GO:0045830) | 2.59563814 |
| 69 | positive regulation of defense response to virus by host (GO:0002230) | 2.58551478 |
| 70 | cellular response to ATP (GO:0071318) | 2.58394908 |
| 71 | indole-containing compound metabolic process (GO:0042430) | 2.57955622 |
| 72 | regulation of immunoglobulin secretion (GO:0051023) | 2.56527043 |
| 73 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.55868194 |
| 74 | T cell costimulation (GO:0031295) | 2.55118811 |
| 75 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.52752178 |
| 76 | negative regulation of T cell mediated immunity (GO:0002710) | 2.52659405 |
| 77 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.52247338 |
| 78 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.50995895 |
| 79 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.50995895 |
| 80 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.50995895 |
| 81 | lymphocyte costimulation (GO:0031294) | 2.50093793 |
| 82 | positive regulation of interleukin-2 production (GO:0032743) | 2.49527562 |
| 83 | sulfation (GO:0051923) | 2.49457123 |
| 84 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.47851400 |
| 85 | protein carboxylation (GO:0018214) | 2.47271720 |
| 86 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.47271720 |
| 87 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.46800784 |
| 88 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.46594413 |
| 89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.45399705 |
| 90 | T cell differentiation involved in immune response (GO:0002292) | 2.43344625 |
| 91 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.43344625 |
| 92 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.43344625 |
| 93 | negative regulation of protein oligomerization (GO:0032460) | 2.43299566 |
| 94 | negative regulation of bone resorption (GO:0045779) | 2.41682078 |
| 95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.41500238 |
| 96 | adaptation of signaling pathway (GO:0023058) | 2.41333502 |
| 97 | cAMP catabolic process (GO:0006198) | 2.40322565 |
| 98 | proline transport (GO:0015824) | 2.39943789 |
| 99 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.39823106 |
| 100 | neural tube formation (GO:0001841) | 2.38799044 |
| 101 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.38172961 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.38098107 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.37699684 |
| 104 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.37699684 |
| 105 | detection of calcium ion (GO:0005513) | 2.37635011 |
| 106 | COPII vesicle coating (GO:0048208) | 2.37108029 |
| 107 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.36358342 |
| 108 | serotonin metabolic process (GO:0042428) | 2.35418949 |
| 109 | lipid translocation (GO:0034204) | 2.35105286 |
| 110 | phospholipid translocation (GO:0045332) | 2.35105286 |
| 111 | superoxide anion generation (GO:0042554) | 2.34942630 |
| 112 | endoderm formation (GO:0001706) | 2.34934149 |
| 113 | thyroid hormone metabolic process (GO:0042403) | 2.34639610 |
| 114 | regulation of isotype switching (GO:0045191) | 2.34477740 |
| 115 | NAD biosynthetic process (GO:0009435) | 2.33582824 |
| 116 | cyclic nucleotide catabolic process (GO:0009214) | 2.33561378 |
| 117 | insulin secretion (GO:0030073) | 2.33035356 |
| 118 | positive regulation of vesicle fusion (GO:0031340) | 2.31058515 |
| 119 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.30872780 |
| 120 | regulation of beta-amyloid formation (GO:1902003) | 2.30867890 |
| 121 | regulation of T-helper 1 type immune response (GO:0002825) | 2.29543133 |
| 122 | regulation of mesoderm development (GO:2000380) | 2.29142104 |
| 123 | regulation of ARF protein signal transduction (GO:0032012) | 2.28844303 |
| 124 | alpha-beta T cell differentiation (GO:0046632) | 2.28232831 |
| 125 | thrombin receptor signaling pathway (GO:0070493) | 2.27662375 |
| 126 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.27438125 |
| 127 | negative regulation of mast cell activation (GO:0033004) | 2.26880326 |
| 128 | keratinization (GO:0031424) | 2.26796063 |
| 129 | primary amino compound metabolic process (GO:1901160) | 2.26058477 |
| 130 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.25677928 |
| 131 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.25533088 |
| 132 | regulation of chronic inflammatory response (GO:0002676) | 2.25287241 |
| 133 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.25122231 |
| 134 | response to pheromone (GO:0019236) | 2.24623228 |
| 135 | photoreceptor cell maintenance (GO:0045494) | 2.24120636 |
| 136 | synaptic vesicle maturation (GO:0016188) | 2.23943080 |
| 137 | signal peptide processing (GO:0006465) | 2.22946918 |
| 138 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.22814556 |
| 139 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.22516620 |
| 140 | cellular zinc ion homeostasis (GO:0006882) | 2.20813337 |
| 141 | regulation of response to tumor cell (GO:0002834) | 2.20614421 |
| 142 | positive regulation of response to tumor cell (GO:0002836) | 2.20614421 |
| 143 | positive regulation of immune response to tumor cell (GO:0002839) | 2.20614421 |
| 144 | regulation of immune response to tumor cell (GO:0002837) | 2.20614421 |
| 145 | DNA deamination (GO:0045006) | 2.20532673 |
| 146 | positive regulation of DNA recombination (GO:0045911) | 2.19874860 |
| 147 | positive regulation of immunoglobulin production (GO:0002639) | 2.19823923 |
| 148 | positive regulation of histone deacetylation (GO:0031065) | 2.19712519 |
| 149 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.18990797 |
| 150 | T cell migration (GO:0072678) | 2.18762075 |
| 151 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.18748885 |
| 152 | neuronal action potential (GO:0019228) | 2.18741292 |
| 153 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.18720361 |
| 154 | peptide hormone processing (GO:0016486) | 2.18333516 |
| 155 | alpha-beta T cell activation (GO:0046631) | 2.17648853 |
| 156 | magnesium ion transport (GO:0015693) | 2.17454743 |
| 157 | cellular response to growth hormone stimulus (GO:0071378) | 2.17135310 |
| 158 | kidney morphogenesis (GO:0060993) | 2.14169726 |
| 159 | parturition (GO:0007567) | 2.13948599 |
| 160 | benzene-containing compound metabolic process (GO:0042537) | 2.12650707 |
| 161 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.12135028 |
| 162 | aromatic amino acid family catabolic process (GO:0009074) | 2.10936180 |
| 163 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.10878014 |
| 164 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.10355379 |
| 165 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.09034354 |
| 166 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.07629791 |
| 167 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.07603399 |
| 168 | protein K48-linked deubiquitination (GO:0071108) | 2.07446036 |
| 169 | regulation of establishment of cell polarity (GO:2000114) | 2.07361446 |
| 170 | cellular response to exogenous dsRNA (GO:0071360) | 2.06822995 |
| 171 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.05632720 |
| 172 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.05412632 |
| 173 | keratinocyte development (GO:0003334) | 2.04737842 |
| 174 | dopamine transport (GO:0015872) | 2.04250122 |
| 175 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.03689368 |
| 176 | cellular ketone body metabolic process (GO:0046950) | 2.03351974 |
| 177 | protein K63-linked deubiquitination (GO:0070536) | 2.03236274 |
| 178 | sphingoid metabolic process (GO:0046519) | 2.03032291 |
| 179 | multicellular organism reproduction (GO:0032504) | 2.02454217 |
| 180 | negative regulation of lipid storage (GO:0010888) | 2.00914299 |
| 181 | negative regulation of interleukin-1 production (GO:0032692) | 2.00262217 |
| 182 | platelet dense granule organization (GO:0060155) | 1.99707460 |
| 183 | positive regulation of fatty acid transport (GO:2000193) | 1.99606921 |
| 184 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 1.98440928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.69539615 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.00190864 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.16482139 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90865004 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.81739341 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.77630614 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.53804916 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.40262295 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37069516 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.36881640 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34463378 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.31626375 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23684323 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15152043 |
| 15 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.03973098 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95905595 |
| 17 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95658421 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90512826 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.80959511 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68710564 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.67904108 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.65303889 |
| 23 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.65249221 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64980317 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59061815 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59034586 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55421661 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51120411 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49347575 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.47450993 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47359349 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45904705 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45592582 |
| 34 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43862003 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40617903 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39906614 |
| 37 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38514685 |
| 38 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37794175 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37564071 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37229529 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36018420 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35192015 |
| 43 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34290788 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33533139 |
| 45 | * MYB_26560356_Chip-Seq_TH2_Human | 1.33074663 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33007153 |
| 47 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32284046 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31488966 |
| 49 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30287256 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29652286 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28741376 |
| 52 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27000391 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25879199 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.25519454 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25473873 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25452160 |
| 57 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22802499 |
| 58 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22421794 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22011082 |
| 60 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21626251 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21122462 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21101361 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21101361 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20564601 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20422806 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19463758 |
| 67 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19346355 |
| 68 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.19197152 |
| 69 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19181248 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18638857 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18047904 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18047904 |
| 73 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17866218 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17799999 |
| 75 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17206490 |
| 76 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16634660 |
| 77 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15909877 |
| 78 | * MYB_26560356_Chip-Seq_TH1_Human | 1.15018068 |
| 79 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14877166 |
| 80 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14794602 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14544263 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13855755 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13650533 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12432824 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11515057 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11421785 |
| 87 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.10574772 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10286783 |
| 89 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09982189 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09374320 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08681455 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08567032 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08343260 |
| 94 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07845395 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07441993 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07441993 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06621784 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06180591 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06180591 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05550161 |
| 101 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04324754 |
| 102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04163367 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03566792 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03283972 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02491749 |
| 106 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01186648 |
| 107 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00982276 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99763528 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99453125 |
| 110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95252274 |
| 111 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94208178 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93445862 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93152739 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93035676 |
| 115 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92846817 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92023447 |
| 117 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.90324732 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89086247 |
| 119 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87615075 |
| 120 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.87453797 |
| 121 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87109763 |
| 122 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86887842 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86567340 |
| 124 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85743836 |
| 125 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85623036 |
| 126 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84780155 |
| 127 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84246304 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84188203 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84036224 |
| 130 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83247167 |
| 131 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.81152649 |
| 132 | AR_19668381_ChIP-Seq_PC3_Human | 0.81033683 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80785456 |
| 134 | TCF4_23295773_ChIP-Seq_U87_Human | 0.80546479 |
| 135 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.80096403 |
| 136 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.79960880 |
| 137 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79424248 |
| 138 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.79264889 |
| 139 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.79192950 |
| 140 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.78259641 |
| 141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78160023 |
| 142 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.77960496 |
| 143 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77747383 |
| 144 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.77312373 |
| 145 | P300_19829295_ChIP-Seq_ESCs_Human | 0.77239508 |
| 146 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.76924310 |
| 147 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76444081 |
| 148 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.76173928 |
| 149 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.76125488 |
| 150 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.75837052 |
| 151 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.75542773 |
| 152 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.74792390 |
| 153 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74610930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.67816625 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.51529615 |
| 3 | MP0005671_abnormal_response_to | 2.93629823 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 2.88680510 |
| 5 | MP0003252_abnormal_bile_duct | 2.57049364 |
| 6 | MP0005365_abnormal_bile_salt | 2.47796464 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.40020896 |
| 8 | MP0000013_abnormal_adipose_tissue | 2.39694759 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.38321381 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.37486335 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34902950 |
| 12 | MP0002693_abnormal_pancreas_physiology | 2.27982187 |
| 13 | MP0003045_fibrosis | 2.26543003 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.17412318 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.13828427 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.08409369 |
| 17 | MP0005387_immune_system_phenotype | 2.05292296 |
| 18 | MP0001790_abnormal_immune_system | 2.05292296 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.03797528 |
| 20 | MP0003195_calcinosis | 2.00733155 |
| 21 | MP0004043_abnormal_pH_regulation | 1.99978251 |
| 22 | MP0000383_abnormal_hair_follicle | 1.95409412 |
| 23 | MP0005360_urolithiasis | 1.94991132 |
| 24 | MP0004947_skin_inflammation | 1.94426875 |
| 25 | MP0003436_decreased_susceptibility_to | 1.94061206 |
| 26 | MP0006082_CNS_inflammation | 1.87555178 |
| 27 | MP0003303_peritoneal_inflammation | 1.84506476 |
| 28 | MP0003866_abnormal_defecation | 1.81153953 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.77868873 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.76970629 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.76245423 |
| 32 | MP0000685_abnormal_immune_system | 1.75462235 |
| 33 | MP0000427_abnormal_hair_cycle | 1.73084084 |
| 34 | MP0008004_abnormal_stomach_pH | 1.68128364 |
| 35 | MP0001800_abnormal_humoral_immune | 1.63446422 |
| 36 | MP0001944_abnormal_pancreas_morphology | 1.61385622 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.61278490 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.61222151 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.60808751 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.60432372 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.59734356 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.57738614 |
| 43 | MP0010678_abnormal_skin_adnexa | 1.56316337 |
| 44 | MP0008872_abnormal_physiological_respon | 1.55837196 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.55031934 |
| 46 | MP0002822_catalepsy | 1.54742727 |
| 47 | MP0003868_abnormal_feces_composition | 1.51235519 |
| 48 | MP0004130_abnormal_muscle_cell | 1.49071929 |
| 49 | MP0004885_abnormal_endolymph | 1.44202197 |
| 50 | MP0002102_abnormal_ear_morphology | 1.43395751 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.43169245 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.42908685 |
| 53 | MP0000230_abnormal_systemic_arterial | 1.42219696 |
| 54 | MP0006054_spinal_hemorrhage | 1.41684652 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.41629257 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.41396011 |
| 57 | MP0003646_muscle_fatigue | 1.39457764 |
| 58 | MP0002723_abnormal_immune_serum | 1.38410383 |
| 59 | MP0005310_abnormal_salivary_gland | 1.38128577 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.37340061 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.35323242 |
| 62 | MP0003724_increased_susceptibility_to | 1.33140628 |
| 63 | MP0004510_myositis | 1.30899446 |
| 64 | MP0002928_abnormal_bile_duct | 1.28875197 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 1.28823773 |
| 66 | MP0004142_abnormal_muscle_tone | 1.26973011 |
| 67 | MP0009785_altered_susceptibility_to | 1.23269980 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.19626463 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.18757861 |
| 70 | MP0000609_abnormal_liver_physiology | 1.18078964 |
| 71 | MP0002006_tumorigenesis | 1.17825673 |
| 72 | MP0002148_abnormal_hypersensitivity_rea | 1.17719555 |
| 73 | MP0010329_abnormal_lipoprotein_level | 1.17713594 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 1.17150513 |
| 75 | MP0004381_abnormal_hair_follicle | 1.15686109 |
| 76 | MP0000003_abnormal_adipose_tissue | 1.14494158 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.14426430 |
| 78 | MP0002405_respiratory_system_inflammati | 1.14249228 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.12666928 |
| 80 | MP0001984_abnormal_olfaction | 1.12602681 |
| 81 | MP0005025_abnormal_response_to | 1.12299093 |
| 82 | MP0001986_abnormal_taste_sensitivity | 1.11869074 |
| 83 | MP0001819_abnormal_immune_cell | 1.11626673 |
| 84 | MP0004859_abnormal_synaptic_plasticity | 1.11553055 |
| 85 | MP0003880_abnormal_central_pattern | 1.11077613 |
| 86 | MP0003879_abnormal_hair_cell | 1.10727038 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.10481652 |
| 88 | MP0005379_endocrine/exocrine_gland_phen | 1.10277731 |
| 89 | MP0002736_abnormal_nociception_after | 1.09829895 |
| 90 | MP0001666_abnormal_nutrient_absorption | 1.09237947 |
| 91 | MP0002168_other_aberrant_phenotype | 1.09113131 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 1.07381382 |
| 93 | MP0002064_seizures | 1.07338314 |
| 94 | MP0003011_delayed_dark_adaptation | 1.04284870 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 1.02315917 |
| 96 | MP0002272_abnormal_nervous_system | 1.01309220 |
| 97 | MP0001873_stomach_inflammation | 0.98593868 |
| 98 | MP0000604_amyloidosis | 0.98373677 |
| 99 | MP0005535_abnormal_body_temperature | 0.98335536 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.98233213 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.98075617 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 0.97826887 |
| 103 | MP0002254_reproductive_system_inflammat | 0.97450619 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.97223786 |
| 105 | MP0005253_abnormal_eye_physiology | 0.96781099 |
| 106 | MP0004019_abnormal_vitamin_homeostasis | 0.96722692 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.95967725 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.94346412 |
| 109 | MP0004742_abnormal_vestibular_system | 0.93662595 |
| 110 | MP0001919_abnormal_reproductive_system | 0.93455094 |
| 111 | MP0005448_abnormal_energy_balance | 0.93305592 |
| 112 | MP0003890_abnormal_embryonic-extraembry | 0.92814320 |
| 113 | MP0001756_abnormal_urination | 0.90720378 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 0.90193926 |
| 115 | MP0005389_reproductive_system_phenotype | 0.89780666 |
| 116 | MP0001663_abnormal_digestive_system | 0.88992858 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.88725838 |
| 118 | MP0002998_abnormal_bone_remodeling | 0.88513877 |
| 119 | MP0008469_abnormal_protein_level | 0.86827323 |
| 120 | MP0002398_abnormal_bone_marrow | 0.86366610 |
| 121 | MP0005023_abnormal_wound_healing | 0.85898027 |
| 122 | MP0005410_abnormal_fertilization | 0.85462659 |
| 123 | MP0004270_analgesia | 0.85194202 |
| 124 | MP0003633_abnormal_nervous_system | 0.84792242 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.84520990 |
| 126 | MP0003091_abnormal_cell_migration | 0.84430532 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.82959171 |
| 128 | MP0009764_decreased_sensitivity_to | 0.81730227 |
| 129 | MP0000716_abnormal_immune_system | 0.80800421 |
| 130 | MP0002419_abnormal_innate_immunity | 0.80700576 |
| 131 | MP0001664_abnormal_digestion | 0.80214307 |
| 132 | MP0009046_muscle_twitch | 0.78738483 |
| 133 | MP0001765_abnormal_ion_homeostasis | 0.77656515 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.76089870 |
| 135 | MP0002896_abnormal_bone_mineralization | 0.76028393 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.75075719 |
| 137 | MP0009745_abnormal_behavioral_response | 0.74602256 |
| 138 | MP0003283_abnormal_digestive_organ | 0.73457903 |
| 139 | MP0009763_increased_sensitivity_to | 0.73417112 |
| 140 | MP0008569_lethality_at_weaning | 0.73154532 |
| 141 | MP0000569_abnormal_digit_pigmentation | 0.72564485 |
| 142 | MP0001299_abnormal_eye_distance/ | 0.71489495 |
| 143 | MP0001881_abnormal_mammary_gland | 0.71211393 |
| 144 | MP0000858_altered_metastatic_potential | 0.70482256 |
| 145 | MP0003787_abnormal_imprinting | 0.69915383 |
| 146 | MP0002118_abnormal_lipid_homeostasis | 0.69780016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.70959465 |
| 2 | Genetic anticipation (HP:0003743) | 3.66194736 |
| 3 | Hyperventilation (HP:0002883) | 3.60522901 |
| 4 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51534499 |
| 5 | Hypoglycemic seizures (HP:0002173) | 3.44031792 |
| 6 | T lymphocytopenia (HP:0005403) | 3.43274190 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.37714950 |
| 8 | Congenital stationary night blindness (HP:0007642) | 3.35406164 |
| 9 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.29297919 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.28226260 |
| 11 | Stomach cancer (HP:0012126) | 3.27745382 |
| 12 | Pancreatic cysts (HP:0001737) | 3.24888094 |
| 13 | Joint swelling (HP:0001386) | 3.13074180 |
| 14 | Hyperglycemia (HP:0003074) | 3.10700223 |
| 15 | Decreased circulating renin level (HP:0003351) | 3.07357834 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.03485934 |
| 17 | Optic neuritis (HP:0100653) | 3.03485934 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.02633246 |
| 19 | Symptomatic seizures (HP:0011145) | 3.01973798 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.95029814 |
| 21 | Myocardial infarction (HP:0001658) | 2.87903389 |
| 22 | Abnormality of the renal cortex (HP:0011035) | 2.84474254 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 2.84228873 |
| 24 | Congenital sensorineural hearing impairment (HP:0008527) | 2.83282404 |
| 25 | Stomatitis (HP:0010280) | 2.81359557 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.78358889 |
| 27 | Hypoglycemic coma (HP:0001325) | 2.73357550 |
| 28 | Arterial thrombosis (HP:0004420) | 2.70609511 |
| 29 | Orchitis (HP:0100796) | 2.69953713 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64002311 |
| 31 | Furrowed tongue (HP:0000221) | 2.63043768 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.58455139 |
| 33 | Absent/shortened dynein arms (HP:0200106) | 2.58455139 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.58436083 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.58436083 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.58298684 |
| 37 | True hermaphroditism (HP:0010459) | 2.57931259 |
| 38 | Myositis (HP:0100614) | 2.56209778 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54384933 |
| 40 | Dysmetric saccades (HP:0000641) | 2.51460352 |
| 41 | Abolished electroretinogram (ERG) (HP:0000550) | 2.50864918 |
| 42 | Prolonged partial thromboplastin time (HP:0003645) | 2.49494422 |
| 43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49096415 |
| 44 | Pustule (HP:0200039) | 2.44970109 |
| 45 | Focal motor seizures (HP:0011153) | 2.43859597 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43762454 |
| 47 | Increased IgE level (HP:0003212) | 2.43482607 |
| 48 | Atonic seizures (HP:0010819) | 2.43242447 |
| 49 | Hematochezia (HP:0002573) | 2.42893859 |
| 50 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.41084705 |
| 51 | Fair hair (HP:0002286) | 2.40934977 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.39953657 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.39797944 |
| 54 | Chronic diarrhea (HP:0002028) | 2.39113224 |
| 55 | Absence seizures (HP:0002121) | 2.38271093 |
| 56 | Impaired smooth pursuit (HP:0007772) | 2.35263759 |
| 57 | Clumsiness (HP:0002312) | 2.34167047 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.32629546 |
| 59 | Parakeratosis (HP:0001036) | 2.30613149 |
| 60 | Attenuation of retinal blood vessels (HP:0007843) | 2.30415196 |
| 61 | Inability to walk (HP:0002540) | 2.29063412 |
| 62 | Hemiplegia (HP:0002301) | 2.27731738 |
| 63 | Nephronophthisis (HP:0000090) | 2.27670016 |
| 64 | Abnormality of the renal medulla (HP:0100957) | 2.27488240 |
| 65 | Abnormality of alanine metabolism (HP:0010916) | 2.27351499 |
| 66 | Hyperalaninemia (HP:0003348) | 2.27351499 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27351499 |
| 68 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25268535 |
| 69 | Abnormality of T cells (HP:0002843) | 2.24945099 |
| 70 | Tubular atrophy (HP:0000092) | 2.24620944 |
| 71 | Febrile seizures (HP:0002373) | 2.24452142 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24022080 |
| 73 | Abnormality of secondary sexual hair (HP:0009888) | 2.22554579 |
| 74 | Abnormality of the axillary hair (HP:0100134) | 2.22554579 |
| 75 | Progressive inability to walk (HP:0002505) | 2.20761101 |
| 76 | Mitral stenosis (HP:0001718) | 2.20323486 |
| 77 | Congenital, generalized hypertrichosis (HP:0004540) | 2.19876074 |
| 78 | Deep venous thrombosis (HP:0002625) | 2.19719396 |
| 79 | Absent speech (HP:0001344) | 2.16907171 |
| 80 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16466055 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.16466055 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15605783 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.15049014 |
| 84 | Recurrent fungal infections (HP:0002841) | 2.14860512 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.13944189 |
| 86 | Abnormal drinking behavior (HP:0030082) | 2.12949352 |
| 87 | Polydipsia (HP:0001959) | 2.12949352 |
| 88 | Tetraplegia (HP:0002445) | 2.10380452 |
| 89 | Chronic hepatic failure (HP:0100626) | 2.09765967 |
| 90 | Increased CSF protein (HP:0002922) | 2.09218844 |
| 91 | Xanthomatosis (HP:0000991) | 2.08471270 |
| 92 | Retinal atrophy (HP:0001105) | 2.08350682 |
| 93 | Gangrene (HP:0100758) | 2.08183577 |
| 94 | IgA deficiency (HP:0002720) | 2.07547798 |
| 95 | Skin nodule (HP:0200036) | 2.07347817 |
| 96 | Abnormality of renin-angiotensin system (HP:0000847) | 2.07199878 |
| 97 | Renal cortical cysts (HP:0000803) | 2.05904477 |
| 98 | Menorrhagia (HP:0000132) | 2.05587181 |
| 99 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.05011777 |
| 100 | Abnormal ciliary motility (HP:0012262) | 2.04991970 |
| 101 | Lip pit (HP:0100267) | 2.03866215 |
| 102 | Prostate neoplasm (HP:0100787) | 2.03560817 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03160248 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03160248 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03160248 |
| 106 | Prolonged bleeding time (HP:0003010) | 2.01517564 |
| 107 | Decreased central vision (HP:0007663) | 2.01021602 |
| 108 | Protruding tongue (HP:0010808) | 2.00499093 |
| 109 | Recurrent bronchitis (HP:0002837) | 1.98296017 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98105495 |
| 111 | Macroorchidism (HP:0000053) | 1.98099065 |
| 112 | Short hallux (HP:0010109) | 1.94318054 |
| 113 | Hemoptysis (HP:0002105) | 1.93505326 |
| 114 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.92803060 |
| 115 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.92803060 |
| 116 | Gingival bleeding (HP:0000225) | 1.92090260 |
| 117 | Anorexia (HP:0002039) | 1.91825408 |
| 118 | Widely spaced teeth (HP:0000687) | 1.91678860 |
| 119 | Cystic liver disease (HP:0006706) | 1.91047617 |
| 120 | Hypochromic microcytic anemia (HP:0004840) | 1.90328516 |
| 121 | Pulmonary embolism (HP:0002204) | 1.89763509 |
| 122 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89410374 |
| 123 | Hypothermia (HP:0002045) | 1.89262742 |
| 124 | Medial flaring of the eyebrow (HP:0010747) | 1.87548659 |
| 125 | Type II lissencephaly (HP:0007260) | 1.87165400 |
| 126 | Broad-based gait (HP:0002136) | 1.85479056 |
| 127 | Metabolic alkalosis (HP:0200114) | 1.84848550 |
| 128 | Papilledema (HP:0001085) | 1.83448351 |
| 129 | Thyroiditis (HP:0100646) | 1.83033880 |
| 130 | Recurrent bacterial skin infections (HP:0005406) | 1.82236536 |
| 131 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.81555222 |
| 132 | Erythroderma (HP:0001019) | 1.81521938 |
| 133 | Visual hallucinations (HP:0002367) | 1.81296664 |
| 134 | Focal seizures (HP:0007359) | 1.80900020 |
| 135 | Vasculitis (HP:0002633) | 1.80297894 |
| 136 | Generalized hypopigmentation of hair (HP:0011358) | 1.79824517 |
| 137 | Hypoplastic labia majora (HP:0000059) | 1.79572301 |
| 138 | Hypoalphalipoproteinemia (HP:0003233) | 1.78704331 |
| 139 | Disproportionate short-trunk short stature (HP:0003521) | 1.78207928 |
| 140 | Diplopia (HP:0000651) | 1.78133568 |
| 141 | Abnormality of binocular vision (HP:0011514) | 1.78133568 |
| 142 | Increased IgM level (HP:0003496) | 1.77834546 |
| 143 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77598913 |
| 144 | Hypoplasia of the fovea (HP:0007750) | 1.77598913 |
| 145 | Complement deficiency (HP:0004431) | 1.77536718 |
| 146 | IgG deficiency (HP:0004315) | 1.77241001 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.76769944 |
| 148 | Joint hemorrhage (HP:0005261) | 1.75870018 |
| 149 | Chronic otitis media (HP:0000389) | 1.75674112 |
| 150 | Epileptiform EEG discharges (HP:0011182) | 1.75472886 |
| 151 | EEG with generalized epileptiform discharges (HP:0011198) | 1.75464891 |
| 152 | Epidermoid cyst (HP:0200040) | 1.74573320 |
| 153 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.74016682 |
| 154 | Recurrent viral infections (HP:0004429) | 1.73808848 |
| 155 | Dialeptic seizures (HP:0011146) | 1.73786985 |
| 156 | Hyperlipoproteinemia (HP:0010980) | 1.73467080 |
| 157 | Large for gestational age (HP:0001520) | 1.71831542 |
| 158 | Striae distensae (HP:0001065) | 1.71704168 |
| 159 | Aneurysm (HP:0002617) | 1.71296918 |
| 160 | Abnormality of T cell physiology (HP:0011840) | 1.69263833 |
| 161 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.69165457 |
| 162 | Dysostosis multiplex (HP:0000943) | 1.68962866 |
| 163 | Vacuolated lymphocytes (HP:0001922) | 1.68830273 |
| 164 | Autoimmune thrombocytopenia (HP:0001973) | 1.68704494 |
| 165 | Blue irides (HP:0000635) | 1.68702899 |
| 166 | Chorioretinal atrophy (HP:0000533) | 1.68295943 |
| 167 | Periodontitis (HP:0000704) | 1.67832352 |
| 168 | Status epilepticus (HP:0002133) | 1.67694257 |
| 169 | Abnormality of the nasal septum (HP:0000419) | 1.66585451 |
| 170 | Asplenia (HP:0001746) | 1.66547935 |
| 171 | Palmoplantar hyperkeratosis (HP:0000972) | 1.66202350 |
| 172 | Scanning speech (HP:0002168) | 1.66019288 |
| 173 | Agitation (HP:0000713) | 1.65964531 |
| 174 | Truncal ataxia (HP:0002078) | 1.65613232 |
| 175 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.65564625 |
| 176 | Vertebral arch anomaly (HP:0008438) | 1.64848469 |
| 177 | Resting tremor (HP:0002322) | 1.64617775 |
| 178 | Hypsarrhythmia (HP:0002521) | 1.63905449 |
| 179 | Glucose intolerance (HP:0000833) | 1.61445685 |
| 180 | Limb hypertonia (HP:0002509) | 1.61095886 |
| 181 | Type I diabetes mellitus (HP:0100651) | 1.60974572 |
| 182 | Coarse hair (HP:0002208) | 1.60078135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.04985213 |
| 2 | TXK | 3.86492659 |
| 3 | INSRR | 3.16727199 |
| 4 | TAOK3 | 3.07932794 |
| 5 | ADRBK2 | 3.00830937 |
| 6 | MAP3K14 | 2.80422336 |
| 7 | JAK1 | 2.76045821 |
| 8 | FGFR4 | 2.71629063 |
| 9 | BMPR1B | 2.63871349 |
| 10 | JAK3 | 2.44721837 |
| 11 | FRK | 2.35957130 |
| 12 | EPHA3 | 2.33855405 |
| 13 | MAP4K1 | 2.28658658 |
| 14 | FGFR3 | 2.21956190 |
| 15 | NTRK3 | 2.07802938 |
| 16 | MAP3K13 | 1.97329403 |
| 17 | ITK | 1.93405516 |
| 18 | TYK2 | 1.92133027 |
| 19 | GRK1 | 1.90843476 |
| 20 | TNIK | 1.90694973 |
| 21 | MAP3K2 | 1.87863497 |
| 22 | PRKCH | 1.69227161 |
| 23 | WNK3 | 1.62960592 |
| 24 | MST4 | 1.53764321 |
| 25 | CASK | 1.49448318 |
| 26 | OXSR1 | 1.44704894 |
| 27 | ZAP70 | 1.43933495 |
| 28 | CDK12 | 1.43819662 |
| 29 | JAK2 | 1.43231330 |
| 30 | RIPK4 | 1.42621642 |
| 31 | HIPK2 | 1.39866228 |
| 32 | STK39 | 1.39716087 |
| 33 | AKT3 | 1.38032986 |
| 34 | CAMKK2 | 1.35471798 |
| 35 | IKBKE | 1.29332865 |
| 36 | FGFR2 | 1.27994304 |
| 37 | PINK1 | 1.27023486 |
| 38 | NUAK1 | 1.25256761 |
| 39 | MAP3K9 | 1.24793716 |
| 40 | STK24 | 1.22804708 |
| 41 | IRAK3 | 1.22240566 |
| 42 | WNK4 | 1.20310018 |
| 43 | PTK2B | 1.18217262 |
| 44 | SIK2 | 1.17245080 |
| 45 | BMPR2 | 1.15417100 |
| 46 | TGFBR1 | 1.15044038 |
| 47 | CAMKK1 | 1.13400827 |
| 48 | PTK6 | 1.12867791 |
| 49 | MAP3K1 | 1.12269239 |
| 50 | PRKD3 | 1.09919426 |
| 51 | MAP3K7 | 1.08695291 |
| 52 | SIK1 | 1.08240838 |
| 53 | GRK7 | 1.06822925 |
| 54 | ADRBK1 | 1.04594640 |
| 55 | FER | 1.01093625 |
| 56 | SGK3 | 0.99249027 |
| 57 | MAPK13 | 0.98822484 |
| 58 | RIPK1 | 0.98533404 |
| 59 | CSK | 0.95617371 |
| 60 | MAP4K2 | 0.94010468 |
| 61 | LCK | 0.93659322 |
| 62 | BTK | 0.93408771 |
| 63 | CDC42BPA | 0.91345479 |
| 64 | ALK | 0.90667035 |
| 65 | PDGFRA | 0.89892482 |
| 66 | RET | 0.88614768 |
| 67 | STK3 | 0.88233391 |
| 68 | TRPM7 | 0.86132991 |
| 69 | PLK2 | 0.86007614 |
| 70 | KSR2 | 0.85932514 |
| 71 | SGK2 | 0.85230235 |
| 72 | MAP2K4 | 0.83529105 |
| 73 | HCK | 0.82562518 |
| 74 | MAP3K4 | 0.81705996 |
| 75 | PDK1 | 0.81342824 |
| 76 | SGK494 | 0.80748828 |
| 77 | SGK223 | 0.80748828 |
| 78 | CHUK | 0.80527614 |
| 79 | PRKCQ | 0.80482370 |
| 80 | WNK1 | 0.79806133 |
| 81 | PIK3CA | 0.79608732 |
| 82 | BLK | 0.79602952 |
| 83 | IRAK1 | 0.79562238 |
| 84 | PRKCE | 0.78271078 |
| 85 | PAK3 | 0.76928167 |
| 86 | FGR | 0.74341912 |
| 87 | ZAK | 0.74261389 |
| 88 | CDK6 | 0.74194189 |
| 89 | MARK3 | 0.73476449 |
| 90 | TBK1 | 0.73196888 |
| 91 | GRK6 | 0.72576328 |
| 92 | BMX | 0.72184823 |
| 93 | LYN | 0.71914720 |
| 94 | TLK1 | 0.70427658 |
| 95 | PIK3CG | 0.69566690 |
| 96 | CAMK1G | 0.69393386 |
| 97 | PRKAA2 | 0.69012627 |
| 98 | IKBKB | 0.68899484 |
| 99 | SYK | 0.66016950 |
| 100 | PDGFRB | 0.64913196 |
| 101 | TEC | 0.64903475 |
| 102 | STK38 | 0.64415805 |
| 103 | IRAK4 | 0.64130270 |
| 104 | PTK2 | 0.63998606 |
| 105 | NLK | 0.59988754 |
| 106 | PRKD2 | 0.58946271 |
| 107 | PRKCG | 0.58925017 |
| 108 | NEK9 | 0.58474734 |
| 109 | IGF1R | 0.58417761 |
| 110 | ERN1 | 0.58284736 |
| 111 | PAK6 | 0.58187825 |
| 112 | TNK2 | 0.57091400 |
| 113 | GRK5 | 0.56770617 |
| 114 | KIT | 0.55634445 |
| 115 | NTRK2 | 0.54501241 |
| 116 | MATK | 0.54455339 |
| 117 | ERBB2 | 0.54363673 |
| 118 | MELK | 0.53478458 |
| 119 | ERBB4 | 0.51513874 |
| 120 | STK38L | 0.50628846 |
| 121 | MAP3K5 | 0.50138818 |
| 122 | BRSK2 | 0.49690915 |
| 123 | MKNK2 | 0.49664275 |
| 124 | MAP2K6 | 0.48518595 |
| 125 | EPHA2 | 0.47329653 |
| 126 | MAPK15 | 0.46409852 |
| 127 | INSR | 0.46354927 |
| 128 | STK11 | 0.45436757 |
| 129 | SGK1 | 0.45393094 |
| 130 | CAMK1D | 0.44429103 |
| 131 | TRIB3 | 0.43610511 |
| 132 | CAMK2A | 0.42991923 |
| 133 | SIK3 | 0.42628136 |
| 134 | STK10 | 0.41416160 |
| 135 | DAPK2 | 0.41096321 |
| 136 | ABL1 | 0.40494533 |
| 137 | PIM1 | 0.40270978 |
| 138 | PDPK1 | 0.40049435 |
| 139 | MAP2K1 | 0.38609575 |
| 140 | ERBB3 | 0.37994374 |
| 141 | NTRK1 | 0.37277442 |
| 142 | BRD4 | 0.37215957 |
| 143 | FGFR1 | 0.36752184 |
| 144 | LATS1 | 0.36382436 |
| 145 | RPS6KA3 | 0.35379475 |
| 146 | EPHA4 | 0.33402583 |
| 147 | FES | 0.32744450 |
| 148 | EGFR | 0.32488573 |
| 149 | MST1R | 0.32054555 |
| 150 | MAPK7 | 0.31634846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.08116097 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.81920140 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.71158832 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.53544202 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.18469354 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.16342311 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14579460 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14451519 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92908378 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.87636653 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.85088334 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 1.76337135 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.74293106 |
| 14 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.69917274 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.63918938 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48636433 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42159560 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.36562017 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35172306 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28861404 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27246469 |
| 22 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26880347 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26194739 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25417771 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23967353 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22807991 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.22328008 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21843781 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21807694 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19864567 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19077565 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18929347 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18915457 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18647413 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16966819 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16113386 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14778582 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.14136173 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12633296 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11782993 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.08786900 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.08687893 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.08606689 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.06771449 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05696505 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01314228 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01206443 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00908077 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99888968 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.99575892 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99372505 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96879993 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95969190 |
| 54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95830431 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95606973 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.94054334 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93305138 |
| 58 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.93229194 |
| 59 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.92040198 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.91274566 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90778248 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89923423 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89331969 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.88999232 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88502409 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87442427 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.86756185 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84851019 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84217049 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.83158551 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83029050 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.82608673 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.82410210 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81753357 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.81751380 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80154820 |
| 77 | Salivary secretion_Homo sapiens_hsa04970 | 0.78286037 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78275334 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76539473 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75528949 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75303957 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75134939 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.74543156 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73968355 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73963115 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72995434 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72506436 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71604914 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70612777 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70372968 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68512567 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68167073 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67284359 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67028866 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.66905189 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66570366 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.64236018 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64121033 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63794303 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63674382 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63569067 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61983212 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.61865710 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60923369 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60908814 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60488693 |
| 107 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60418625 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59309614 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58600784 |
| 110 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58239135 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58212640 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57761888 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57100586 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56690354 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55951616 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55584575 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.55525301 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55272362 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55153248 |
| 120 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55040927 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54273008 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53621211 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53274733 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52120483 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52047302 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.52016645 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51554214 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50965128 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50534237 |
| 130 | Malaria_Homo sapiens_hsa05144 | 0.50221065 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50213906 |
| 132 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49502767 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49043767 |
| 134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48929504 |
| 135 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47383304 |
| 136 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46941115 |
| 137 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46260646 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.46116574 |
| 139 | Influenza A_Homo sapiens_hsa05164 | 0.45256759 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.45018226 |
| 141 | Legionellosis_Homo sapiens_hsa05134 | 0.44971154 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44749280 |

